The dexamethasone suppression test and unipolar/bipolar distinctions.

Area of Science:

• Psychiatry and Endocrinology
• Neuroscience
• Clinical Psychology

Background:

• Affective disorders encompass a range of mood disturbances.
• Accurate diagnosis and subtype classification are crucial for effective treatment.
• The dexamethasone suppression test (DST) has been explored as a biological marker for depression.

Purpose of the Study:

• To validate affective disorder subtypes using comprehensive diagnostic and phenomenological assessments.
• To investigate the utility of the DST, specifically cortisol levels, in differentiating depressive subtypes.
• To determine if the DST can distinguish bipolar disorder from other affective disorders.

Main Methods:

• A cohort of 52 hospitalized patients with affective disorders was studied.
• Patients underwent comprehensive diagnostic and phenomenological classification.
• Cortisol levels were measured at baseline and after administration of 0.5 mg and 1.0 mg dexamethasone.

Main Results:

• No significant differences in DST response were observed among depressive subtypes with the 1.0 mg dose.
• A significantly different DST response was noted in the bipolar subtype using the 0.5 mg dose.
• Patients with bipolar affective disorder (manic and depressed) showed higher mean post-dexamethasone cortisol levels compared to other groups.

Conclusions:

• The findings support the distinctiveness of the bipolar disorder diagnosis.
• The 0.5 mg DST may serve as a valuable tool in identifying bipolar affective disorder.
• Further research is warranted to explore the neuroendocrine markers in affective disorder subtypes.